GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3526 - 3550 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgG Patient 2 3 mild
G86541PE
522
IgM Patient 2 24 mild
G86541PE
153
IgM Patient 2 3 mild
G86541PE
215
IgA Patient 3 -180 mild
G86541PE
246
IgA Patient 3 11 mild
G86541PE
424
IgG Patient 3 -180 mild
G86541PE
45
IgM Patient 3 -180 mild
G86541PE
64
IgA Patient 3 4 mild
G86541PE
463
IgG Patient 3 11 mild
G86541PE
180
IgG Patient 3 4 mild
G86541PE
165
IgM Patient 3 11 mild
G86541PE
73
IgM Patient 3 4 mild
G86541PE
69
IgA Patient 4 12 mild
G86541PE
361
IgG Patient 4 12 mild
G86541PE
53
IgM Patient 4 12 mild
G86541PE
96
IgA Patient 1 10 moderate
G86566MF
372
IgA Patient 1 22 moderate
G86566MF
334
IgA Patient 1 6 moderate
G86566MF
360
IgG Patient 1 10 moderate
G86566MF
23
IgG Patient 1 22 moderate
G86566MF
22
IgM Patient 1 10 moderate
G86566MF
37
IgM Patient 1 22 moderate
G86566MF
41
IgG Patient 1 6 moderate
G86566MF
22
IgM Patient 1 6 moderate
G86566MF
33
IgA Patient 2 15 mild
G86566MF
347

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024